Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia

Translational Psychiatry
R ShepardL Coutellier

Abstract

Dysfunction of prefrontal parvalbumin (PV+) interneurons has been linked with severe cognitive deficits as observed in several neurodevelopmental disorders including schizophrenia. However, whether a specific aspect of PV+ neurons deregulation, or a specific molecular mechanism within PV+ neurons is responsible for cognitive deficits and other behavioral impairments remain to be determined. Here, we induced cognitive deficits and altered the prefrontal PV system in mice by exposing them neonatally to the NMDA receptor antagonist ketamine. We observed that the cognitive deficits and hyperactivity induced by neonatal ketamine were associated with a downregulation of Npas4 expression specifically in PV+ neurons. To determine whether Npas4 downregulation-induced dysfunction of PV+ neurons could be a molecular contributor to the cognitive and behavioral impairments reported after neonatal ketamine, we used a transgenic Cre-Lox approach. Reduced Npas4 expression within PV+ neurons replicates deficits in short-term memory observed after neonatal ketamine, but does not reproduce disturbances in general activity. Our data show for the first time that the brain-specific transcription factor Npas4 may be an important contributor to PV+ ne...Continue Reading

References

Feb 28, 2002·Nature Neuroscience·Andreas Meyer-LindenbergKaren Faith Berman
May 7, 2002·Learning & Memory·Kevin B Baker, Jeansok J Kim
Mar 21, 2007·Neuroscience and Biobehavioral Reviews·Ekrem DereMaria A De Souza Silva
Dec 7, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cheng Z WangKenneth M Johnson
Apr 28, 2009·Nature·Vikaas S SohalKarl Deisseroth
Dec 14, 2011·Trends in Neurosciences·David A LewisDavid W Volk
Nov 19, 2013·Neurobiology of Disease·Jacquelyn A BrownK Mirnics
Dec 11, 2013·Molecular Psychiatry·M J SchmidtK Mirnics
Jun 3, 2014·Annals of Clinical and Translational Neurology·L CoutellierMehrdad Shamloo
Apr 26, 2015·Behavioural Brain Research·L CoutellierR Shepard
Sep 17, 2015·Nature Reviews. Neuroscience·Michael F GreenJunghee Lee
Jan 16, 2016·Cell·Hoseok KimMarie Carlén
Aug 5, 2017·Science Translational Medicine·Aslihan SelimbeyogluKarl Deisseroth
Aug 16, 2017·Molecular Psychiatry·A AlachkarO Civelli
Dec 12, 2017·Genes, Brain, and Behavior·K Heslin, L Coutellier

Related Concepts

Npas4 protein, mouse
Metazoa
Interneurons
Ketaset
Immediate Recall
Mice, Inbred C57BL
Founder Mice, Transgenic
Parvalbumins
Schizophrenia
N-Methyl-D-Aspartate Receptors

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.